APA (7th ed.) Citation

Haschke, M., Schuster, M., Poglitsch, M., Loibner, H., Salzberg, M., Bruggisser, M., . . . Krähenbühl, S. (2013). Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects. Clinical pharmacokinetics, 52(9), 783-792. https://doi.org/10.1007/s40262-013-0072-7

Chicago Style (17th ed.) Citation

Haschke, Manuel, Manfred Schuster, Marko Poglitsch, Hans Loibner, Marc Salzberg, Marcel Bruggisser, Joseph Penninger, and Stephan Krähenbühl. "Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects." Clinical Pharmacokinetics 52, no. 9 (2013): 783-792. https://doi.org/10.1007/s40262-013-0072-7.

MLA (9th ed.) Citation

Haschke, Manuel, et al. "Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects." Clinical Pharmacokinetics, vol. 52, no. 9, 2013, pp. 783-792, https://doi.org/10.1007/s40262-013-0072-7.